Hugh Young Rienhoff, Jr., M.D., is a San Francisco Bay area physician and entrepreneur. He is the Founder and CEO of Imago BioSciences, his fourth start-up. Previously Hugh founded and was CEO of FerroKin BioSciences until it was acquired by Shire plc in 2012. Hugh spent several years as a venture capitalist and was the first dedicated biotech investing partner at NEA beginning in 1992. Hugh has served on numerous boards including as a founding director of Healtheon/WebMD, Wilson Therapeutics, and Aurora Biosciences. Hugh obtained his Bachelor of Arts degree from Williams College, studied mathematics at Harvard University, and received the Doctor of Medicine degree from the Johns Hopkins University School of Medicine.